Cross-Strand Chimeric RNA Signature Predicts Prognosis and Identifies Tumor Immune Microenvironment Associations in

Shuqiang Cheng1,2, Miaomiao Cui3, Xuehui Li1,2

  • 1Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, China, gmcah.cn.

Human Mutation
|June 22, 2026
PubMed
Summary

This study reveals cross-strand chimeric RNAs (cscRNAs) as key players in gastric cancer, developing a novel prognostic signature for patient risk stratification and identifying potential links to the tumor immune microenvironment.